...

G2211 in Dermatology Billing: Reimbursement, Documentation, and Denial Prevention 

Nurse with elderly patient in wheelchair, titled "G2211 in Dermatology Billing.
Nurse with elderly patient in wheelchair, titled "G2211 in Dermatology Billing.
Touseef Riaz
Written by Touseef Riaz Founder, UControl Billing

G2211 is a Medicare HCPCS Level II add-on code that captures the visit complexity of longitudinal evaluation and management (E/M) care. Dermatology practices report G2211 with an office or outpatient E/M visit (CPT 99202 through 99215) when the dermatologist serves as the ongoing manager of a patient’s serious or complex skin condition. The code took effect on January 1, 2024. It pays the additional cognitive work of managing chronic dermatologic disease across repeated visits, work that the base E/M codes do not fully value. At the 2024 national rate it added roughly $16 per visit, which compounds quickly across a panel of psoriasis, atopic dermatitis, and hidradenitis suppurativa patients. 

G2211 was originally intended for primary care physicians who serve as the “continuing focal point” for all of a patient’s healthcare needs. But dermatologists can use it too. If you are managing a patient’s chronic skin condition over multiple visits, you may qualify for this add-on code. The reimbursement is modest—$16.04 per visit at the Medicare national rate but that amount adds up fast across hundreds of patients with psoriasis, atopic dermatitis, hidradenitis suppurativa, or chronic wounds.

The challenge is that G2211 is also a target for payer scrutiny. Medicare and private insurers are watching how practices use this code. Overuse or incorrect application can trigger claim denials, audits, and recoupments. This blog explains when and how to bill G2211 in dermatology, what documentation protects you, and what mistakes to avoid.

What Is G2211 and Why Does It Matter for Dermatology?

G2211 is a Healthcare Common Procedure Coding System (HCPCS) add-on code that can be reported with outpatient E/M visits. It accounts for the additional resources associated with primary care or similarly ongoing medical care related to a patient’s single serious condition or complex condition.

The code adds 0.49 total relative value units (RVUs) and 0.33 work RVUs to the E/M service. At Medicare’s 2024 national rate, that translated to an additional $16.04 per visit. For a practice that sees hundreds of patients with chronic dermatologic conditions, that extra reimbursement can add up to tens of thousands of dollars annually.

What Makes Dermatology a Good Fit

Dermatologists manage some of the most complex, long-term conditions in medicine. Patients with psoriasis, atopic dermatitis, hidradenitis suppurativa, connective tissue diseases, cutaneous malignancies, chronic wounds, and cutaneous infections often require months or years of ongoing care. These conditions impact quality of life, require treatment adjustments, demand monitoring for side effects, and frequently involve coordination with other specialists.

The complexity of managing these conditions extends beyond what standard E/M codes capture. G2211 was designed to fill that gap. The American Academy of Dermatology has specifically addressed how dermatologists can incorporate this code into their practice.

When G2211 Applies in Dermatology

The code applies when the provider has an ongoing relationship with the patient—not a one-time interaction. 

Here is what qualifies:

  • The provider-patient relationship is well-established, typically spanning six months or more with multiple visits
  • The provider is managing a chronic or serious skin condition such as psoriasis, atopic dermatitis, or chronic wound care
  • The visit involves medical decision-making beyond a one-time assessment, such as modifying therapy, monitoring side effects, or coordinating care with other specialists 

When G2211 Does NOT Apply

There are specific scenarios where you cannot bill G2211:

  • New patients or one-time consultations. No established relationship exists.
  • Visits billed with Modifier 25. Visits billed with Modifier 25, with one finalized exception. For dates of service before January 1, 2025, Medicare denied G2211 whenever the base E/M visit carried Modifier 25. Effective January 1, 2025, the CY2025 Physician Fee Schedule final rule allows G2211 on an E/M visit reported with Modifier 25, but only when the same practitioner furnishes an allowed Part B preventive service on the same day, such as an Annual Wellness Visit, the Initial Preventive Physical Exam, or a vaccine administration. The allowed services are listed in Attachment 1 of CMS Transmittal 13015 (Change Request 13705). Outside that preventive-service set, the Modifier 25 prohibition still stands. 
  • Routine follow-ups without significant medical decision-making. A simple medication refill without treatment changes does not qualify.
  • Primarily procedural visits. If the focus is on performing a treatment rather than care planning, G2211 is not appropriate.
  • When other prolonged service codes would be more appropriate. Codes like 99417 are designed for extended face-to-face time beyond typical E/M visits.

Important update for 2025: CMS proposed allowing G2211 to be billed on the same day as an Annual Wellness Visit, vaccine administration, or other Medicare Part B preventive services. This creates a limited exception to the prohibition on using G2211 with Modifier 25.

G2211 dermatology billing guide infographic for Medicare reimbursement

Documentation That Survives an Audit

What CMS Requires

CMS has not mandated specific, additional documentation for G2211 beyond what you would already document for the E/M visit itself. According to Medicare Learning Network guidance, the visits themselves must be medically reasonable and necessary.

The documentation that supports G2211 includes:

  • Information in the medical record or claims history, such as diagnoses
  • The practitioner’s assessment and plan for the visit
  • Other service codes billed 

CMS medical reviewers may use the medical record to confirm the medical necessity of the visit and the accuracy of time documentation. This means your existing documentation should support G2211 billing.

What Your Notes Should Show?

While CMS has not required extra documentation, your notes should clearly demonstrate the ongoing, longitudinal nature of the relationship and the complexity of care. Here is what that looks like in practice.

  • For a psoriasis patient: “Patient has been under dermatologic care for psoriasis for the past two years, requiring ongoing treatment adjustments. During today’s visit, we reviewed biologic therapy response and modified the dosing schedule to improve efficacy”.
  • For a patient with atopic dermatitis: “Continued long-term management of chronic atopic dermatitis, adjusting treatment based on disease progression. Discussed potential transition to systemic therapy and monitoring needs”.
  • For chronic wound management: “Ongoing longitudinal care for chronic wound management. Reviewed healing progress, adjusted dressing protocol, and coordinated follow-up with vascular surgery”.
  • The key elements are the established relationship, the chronic condition, the ongoing management, and the specific clinical actions taken during the visit.

Documentation Red Flags

Vague or templated notes are a red flag for auditors. If your note simply says “established patient with psoriasis” without describing the ongoing management or treatment changes, it does not support G2211. Notes should explicitly describe the care plan, why the visit was necessary as part of that plan, and the medical decision-making involved.

Common Pitfalls and How to Avoid Them

Billing G2211 with Modifier 25

This is the most common error. G2211 cannot be billed on the same claim as Modifier 25. If you perform a procedure and an E/M on the same day, you use Modifier 25 for the E/M, but you lose the ability to add G2211.

How to avoid it. If a visit involves both a procedure and an E/M, decide which one best represents the primary service. If the E/M is significant and separately identifiable, use Modifier 25 and skip G2211. If the visit is primarily about ongoing management of a chronic condition, you may need to schedule the procedure separately to capture G2211.

Using G2211 for Routine or Time-Limited Encounters

G2211 is not for routine skin checks or acute allergic contact dermatitis. It is for ongoing, complex care. If the patient’s condition is discrete, routine, or time-limited, G2211 does not apply.

How to avoid it. Review each patient’s history before applying G2211. Ask yourself: Am I managing this patient’s condition over time? Is there significant medical decision-making? Is this more than a routine follow-up?

Insufficient Documentation

Vague notes that do not describe the ongoing relationship or the complexity of care are the number one reason G2211 claims get denied on audit.

How to avoid it. Include specific details in every note. Describe the chronic condition, the treatment adjustments, the side effect monitoring, and the care coordination. Avoid generic templates that could apply to any patient.

Assuming All Payers Accept G2211

Medicare introduced G2211, but not all commercial payers have adopted it. Some private insurers may not recognize the code, may require additional documentation, or may have different coverage rules.

How to avoid it. Review each payer’s policy before billing G2211. Keep a payer-specific matrix updated at least annually.

The Reimbursement for G2211

What G2211 Adds

At the Medicare national rate, G2211 adds $16.04 to the E/M reimbursement. For a practice that bills this code on 100 visits per month, that is an additional $1,604 per month, or $19,248 per year. That is real money.

The Audit Risk

Medicare and private payers are closely monitoring G2211 claims. Overuse or incorrect application can result in denials, payment recoupments, or full audits. The practices that succeed with G2211 are the ones that treat documentation as a clinical priority, not an administrative afterthought.

Private Payer Trends

While Medicare introduced G2211, some private insurers are beginning to follow suit. Practices should review payer policies regularly to see if commercial carriers recognize G2211 or offer similar codes for ongoing care. Some insurers may impose additional documentation requirements or require prior authorization for codes similar to G2211.

Practice Checklist for G2211 Compliance

Use this checklist to ensure your practice is billing G2211 correctly:

Before billing:

  • Is the patient established with at least 6 months of care?
  • Is the condition chronic or serious?
  • Does the visit involve more than routine follow-up?
  • Is there documented medical decision-making?
  • Is the patient not a new patient or one-time consult?
  • Is the visit not billed with Modifier 25?

Documentation requirements:

  • The note describes the ongoing, longitudinal relationship
  • The note specifies the chronic condition being managed
  • The note documents treatment adjustments or monitoring
  • The note supports medical necessity for the visit
  • The note avoids vague or templated language

Payer verification:

  • Checked that the payer accepts G2211
  • Verified any specific payer documentation requirements

Conclusion

G2211 is a valuable tool for dermatology practices that manage patients with chronic, complex conditions. The code adds $16.04 to E/M visits, capturing the extra work involved in long-term care that standard codes do not fully reflect.

However, G2211 is also a compliance risk. The code cannot be billed with Modifier 25. It cannot be used for routine or time-limited encounters. Documentation must clearly support the ongoing relationship and the complexity of care.

The practices that succeed with G2211 are the ones that treat documentation as a clinical priority. They train providers on when and how to use the code. They review payer policies regularly. And they conduct internal audits to catch errors before Medicare or commercial payers do.

Stay current with CMS guidance, local Medicare Administrative Contractor policies, and American Academy of Dermatology updates. The rules are not complicated, but they are detailed. Follow them, and G2211 can become a meaningful revenue source for your dermatology practice.

Stop leaving G2211 revenue on the table

Most dermatology practices either miss G2211 on eligible visits or bill it in ways that invite denials and recoupment. UControl Billing Services is a full-service revenue cycle management partner working across all 50 states. Our team audits your E/M claims for missed and at-risk G2211 charges, builds the documentation guardrails that survive review, manages the appeal when a claim is denied, and keeps your coding aligned with the current Medicare rules. Find out where your G2211 capture stands.

[Request a dermatology revenue cycle review]

G2211 Billing Questions Dermatology Practices Ask

Can dermatologists bill G2211?

Yes. Any clinician who reports office or outpatient E/M services can report G2211, including dermatologists. The code is not limited to primary care. It applies when the dermatologist is the ongoing manager of a patient’s serious or complex skin condition, such as psoriasis, hidradenitis suppurativa, or a chronic wound.

How much does G2211 reimburse?

Medicare pays G2211 as its total RVUs multiplied by your locality GPCI and the annual Physician Fee Schedule conversion factor. Because the conversion factor resets each year, the per-visit amount changes annually. At the 2024 national rate it added roughly $16 per visit. Confirm the current figure in the active fee schedule. [VERIFY current-year rate]

Can G2211 be billed with Modifier 25?

Only in the finalized exception effective January 1, 2025. G2211 is payable on an E/M visit with Modifier 25 when the same practitioner furnishes an allowed Part B preventive service that day, such as an Annual Wellness Visit, the Initial Preventive Physical Exam, or a vaccine administration. Outside that set, the prohibition stands.

Can G2211 be billed for new patients?

Yes. G2211 attaches to both new and established patient E/M codes, 99202 through 99215, so a new-patient visit is not automatically disqualified. What disqualifies the code is the absence of ongoing responsibility. A single consult with no intent to assume continuity of care does not support G2211.

What skin conditions qualify for G2211?

Conditions that require ongoing, longitudinal management qualify, including psoriasis, atopic dermatitis, hidradenitis suppurativa, connective tissue disease, cutaneous malignancies, and chronic wounds. CMS does not require a minimum number of conditions or a specific diagnosis. The deciding factor is the continuous care relationship, not the condition itself.

Does G2211 require extra documentation?

No separate G2211 note is required. CMS expects the existing E/M documentation to support medical necessity and to reflect the longitudinal relationship. Your note should name the chronic condition, reference the ongoing care plan, and describe the specific clinical decisions made during the visit. Vague or templated notes will not survive an audit.

Do commercial payers cover G2211?

Coverage varies. G2211 is a Medicare code covered by traditional Part B and many Medicare Advantage plans. Medicaid and commercial payers are not required to cover it, and some do not recognize the code at all. Verify each payer’s policy before billing G2211 broadly. [VERIFY payer-specific policy]

Can G2211 be billed for teledermatology visits?

G2211 may be reported with eligible telehealth E/M services when the payer allows the underlying E/M code and the documentation supports the add-on. The format of the visit does not change the requirement: the continuity relationship and the complexity of ongoing care must still be present in the record.

Is G2211 payable when a procedure is done the same day?

Not in most cases. When a same-day procedure requires Modifier 25 on the E/M, G2211 is not payable unless the additional service is one of the allowed Part B preventive services. If capturing G2211 matters and the procedure is not urgent, scheduling the procedure on a separate date preserves eligibility.

Share this :

Touseef Riaz, Founder and CEO of UControl Billing
Author & Revenue Cycle Management Expert

Founder & CEO at UControl Billing

10+ Years RCM Expertise HIA-LI Member MGMA Member Healthcare Revenue Cycle

A couple of years ago, I executed the effective plan of creating a Medical billing and Coding company named UControl Billing. The company aims to bring revolutionary advancements to foster medical billing and coding revenues. As an official member of HIA-LI and MGMA, I feel honored in providing networking opportunities, problem-solving, and improving the revenue management cycle.

Medical Billing Medical Coding Revenue Cycle Management Practice Revenue Performance Claims & Denials

Amount
You're Missing

We audit your last 30 days of claims and deliver a written report with a real recovery figure

    FREE CONSULTATION

    Get Your Free Billing Review

    Find out how your practice can improve revenue and reduce claim delays.

    ✓ No obligation   |   ✓ Expert RCM Review

    Our Latest Posts

    Scroll to Top